 |
|
|
| |
No Resistance Detected in Four Phase 3 Clinical Studies in HCV Genotypes 1-6 of
Sofosbuvir + Ribavirin With or Without Peginterferon
|
| |
| |
Reported by Jules Levin, NATAP, www.natap.org
AASLD 2013 Nov 1-4 Wash DC
Evguenia S. Svarovskaia,1 Hadas S. Dvory-Sobol,1 Christy Hebner,1 Brian Doehle,1 Viktoria Gontcharova,1 Ross Martin,1 Edward J. Gane,2 Ira M. Jacobson,3
David R. Nelson,4 Eric Lawitz,5 B. Nebiyou Bekele,1 Diana M. Brainard,1 William T. Symonds,1 John G. McHutchison,1 Michael D. Miller,1 Hongmei Mo1
1Gilead Sciences, Inc., Foster City, CA; 2University of Auckland, Auckland City Hospital, New Zealand; 3Weill Cornell Medical College, New York, NY; 4University of Florida, Gainesville; 5Texas Liver Institute, San Antonio, TX
|
| |
|
|
|
|
|
